PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 15, 2017
Insider Transaction Report
Form 4
WILLIAMS NICOLE
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2017-06-14+20,000→ 20,000 totalExercise: $6.95From: 2017-06-14Exp: 2027-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable immediately, on the date of grant.